FITCONN Homecare Medical Equipment Portable Handheld Nebulizador Portatil Inhaler Mesh Nebulizer

Description

Shenzhen Fitconn Technology Co.,ltd was founded in 2012 . It is a comprehensive enterprise dedicated to the research and development, manufacturing, sales and after-sales service of household medical products. The products cover nebulizer (compressor nebulizer, DC Compressor nebulizer and Mesh nebulizer), anti-decubitus air mattress, oximeters, fetal doppler, blood pressure monitors, etc. The business covers more than 150 countries around the world, with an average annual service of more than 2,000,000 family. Fitconn adheres to the concept of create health by heart, and is committed to improving the diversification of atomization methods, let’s households medical products and modern medical technology can benefit thousands of families around the world, with respect, tolerance, integrity, efficiency, innovation and persistence as core values, Integrate superior resources, take innovation as the source of development, and take science and technology as the foundation of success, and strive to provide each consumer with more professional, advanced and safer medical products. Fitconn has the class II medical device production qualification and over 50 patents , the company has passed the 13485 quality system certification, and some products have passed the EU CE and FDA certification

Fitconn MY-123: A Medical-Grade Nebulizer That Weighs Less Than Your Phone

The Fitconn MY-123 does not look like a medical device. At 42 by 55 by 109 millimeters and just 105 grams — about the weight of a tennis ball — it looks like a portable electronic gadget, the kind of thing that belongs in a backpack next to a power bank and a set of wireless earbuds. But this is not a gadget. It is a Class II medical instrument , certified to CE, RoHS, ISO 13485, and MDR EU standards, and it produces a clinically effective aerosol with a median particle size of 2.7 micrometers.

110 KHz and the Physics of Silent Atomization

The MY-123 operates at 110 KHz ± 10 KHz — an ultrasonic frequency that vibrates the mesh plate at a rate calibrated to shear liquid medication into particles in the 3 to 5 micrometer range, with a median of 2.7 μm. This is the clinical band where upper and mid-airway medications achieve peak absorption. The technology is microporous direct atomization — liquid is driven through a perforated membrane at high frequency, producing uniform droplets without heat, without pressure, and without the mechanical noise of a piston compressor.

The result is near-silent operation at ≤50 dB(A) — quieter than a refrigerator, quieter than rainfall, quieter than most ambient indoor environments. For a device this small to be this quiet is not a coincidence. It is the natural acoustic profile of ultrasonic mesh technology, and the MY-123 is engineered to exploit it fully.

Almost Zero Residual: The Efficiency That Adds Up

The MY-123 leaves almost no residual liquid in the medication cup after a treatment cycle. In a category where residual volumes of 1.0 mL or more are common, this is a meaningful specification. A patient using the device three times a day, five days a week, with a standard 3 mL dose, saves approximately 3 mL of medication per day compared to a conventional nebulizer. Over a year, that is nearly a liter of medication that does not go down the drain. For healthcare systems, insurance providers, and individual patients managing chronic conditions, this efficiency translates directly into lower lifetime cost.

Built-In Battery, USB Charging, and the End of Disposable Power

The MY-123 runs on a built-in rechargeable lithium battery, charged through a standard USB cable. This is not a novelty feature. It is a fundamental shift in how the device integrates into daily life. No hunting for AA batteries in a hotel drawer. No carrying a separate pack of alkalines in a travel bag. No environmental guilt about tossing disposable cells into landfill every month. The battery charges from any USB port — a laptop, a car adapter, a power bank, the same cable that charges a phone — and the digital display shows battery level in real time.

This dual-power architecture — battery for cordless portability, USB for recharging — means the MY-123 is genuinely untethered. It does not need to be near a wall outlet. It does not need to be plugged in during use. It simply works wherever the patient happens to be.

The Accessories That Complete the System

The MY-123 ships with everything needed for immediate use: mouthpiece, adult mask, child mask, USB charging cable, and instruction manual. The inclusion of both adult and child masks makes the device family-ready out of the box — a parent treating their own asthma can switch to the child mask for their six-year-old without needing a separate purchase. The extension tube and multiple medication cups support multi-user households and extended treatment cycles.

Packaging is efficient: 42 units per carton, with a gross weight of just 9.5 kilograms and carton dimensions of 47 by 34 by 43.5 centimeters. For a distributor, this means high unit density per shipment and lower freight cost per unit. For a retailer, it means a compact shelf footprint and manageable inventory.

The device is compliant with GB/T18830-2009 safety standards and classified as BF-grade internally powered equipment — the safety classification for devices that make direct or indirect contact with the patient. This is not a consumer electronics toy with a medical label. It is a medical device built to the same safety standards that govern hospital-grade equipment.

Who Should Carry This Product

The MY-123 is the right choice for a distributor targeting the travel and lifestyle segment of the respiratory care market — buyers who need a nebulizer that does not look like a medical device, does not sound like a medical device, and does not behave like a medical device. It is the right choice for a retail channel where aesthetics and portability matter as much as clinical performance — where a nebulizer that fits in a jacket pocket and charges from a laptop is a product that sells itself.

It is also the right choice for any buyer who has watched the nebulizer market split into two tiers: the clinical tier, dominated by bulky compressor units with hospital-grade specifications and hospital-grade inconvenience, and the consumer tier, where portable mesh devices trade clinical credibility for convenience. The MY-123 sits in the narrow space between them — medical-grade certification and consumer-grade portability, combined in a device that weighs 105 grams.

The Fitconn Foundation

The MY-123 comes from Shenzhen Fitconn Technology Co., Ltd. — 21 years in medical device manufacturing, 4.9 out of 5 store rating, 23% reorder rate, and a #1 ranking among household medical device factories on the platform. The company holds ISO 13485 quality management certification and manufactures under MDR EU and CE compliance. With a monthly production capacity of 5,000 pieces and full OEM/ODM capability, Fitconn has the infrastructure to support volume orders without diluting the quality control that earned its certifications.

The Final Word

The Fitconn MY-123 is not the most powerful nebulizer on the market. It is not the cheapest. It is not the one with the most elaborate feature set. What it is — and this is what matters — is the nebulizer that removes the most excuses for not doing the treatment. Too heavy? It weighs 105 grams. Too loud? It runs at under 50 decibels. Needs a power outlet? It charges from USB. Looks like a medical device? It looks like something you would buy at an electronics store. The MY-123 does not ask patients to adapt their lives around their therapy. It adapts the therapy around their lives. That is not a feature list. That is the whole product.